REBECCA SMITH: Open Payments
NPI 1013030949 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,546 in 170 payments from 21 companies in 2025. Trend: 2023 $2,114 · 2024 $3,348 · 2025 $2,546
Food & beverage: $2,546
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 26 | $342 |
| LEO Pharma Inc. | 11 | $281 |
| Janssen Biotech, Inc. | 27 | $256 |
| Novartis Pharmaceuticals Corporation | 6 | $238 |
| ABBVIE INC. | 26 | $218 |
| Amgen Inc. | 13 | $216 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $192 |
| UCB, Inc. | 9 | $181 |
| Organon LLC | 13 | $112 |
| Incyte Corporation | 5 | $91 |
Products named: NEMLUVIO, ADBRY, TREMFYA, OTEZLA, Winlevi, Bimzelx, RINVOQ, OPZELURA.
Industry payments across MO — which companies pay providers there.
